Literature DB >> 12930518

Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria.

I Von Bültzingslöwen1, I Adlerberth, A E Wold, G Dahlén, M Jontell.   

Abstract

Serious systemic infections may occur during cancer chemotherapy due to disturbances in the oropharyngeal and gastrointestinal microflora, impaired mucosal barrier functions and immunosuppression. Bacteria may spread from the gastrointestinal tract to the regional lymph nodes. The routes for bacterial spread from the oral cavity are less well known. In the present study we investigated changes in the oral and intestinal microfloras in rats given 50 mg/kg 5-fluorouracil (5-FU) i.v. for 6 days. Bacterial dissemination to the lymph nodes draining the oral cavity and the lymph nodes draining the gastrointestinal tract was examined. Effects of adding the probiotic strain Lactobacillus plantarum 299v in the drinking water to the rats were measured. 5-FU treatment caused an increase in the number of facultative and strictly anaerobic bacteria in biopsies from the oral cavity and an increase in the number of facultative anaerobes in the large intestine. The proportion of facultative gram-negative rods increased in both the oral cavity and intestine. Bacteria translocated to both the cervical and mesenteric lymph nodes in untreated animals and increased in numbers after 5-FU treatment due to an increase in the number of facultative gram-negative rods. Treatment with L. plantarum 299v improved food intake and body weight in 5-FU-treated rats. It also reduced the 5-FU-induced raise in the total numbers of facultative anaerobes in the intestine, but did not reduce translocation and did not prevent diarrhea. This study reinforces the oral cavity, along with the gastrointestinal tract, as a source for bacterial dissemination. The use of probiotic bacteria may reduce some side effects of 5-FU treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930518     DOI: 10.1034/j.1399-302x.2003.00075.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  29 in total

Review 1.  Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities.

Authors:  Kelley R Jordan; Brett R Loman; Michael T Bailey; Leah M Pyter
Journal:  Cancer       Date:  2018-07-05       Impact factor: 6.860

2.  Live and heat-killed Lactobacillus rhamnosus GG upregulate gene expression of pro-inflammatory cytokines in 5-fluorouracil-pretreated Caco-2 cells.

Authors:  Shiuh-Bin Fang; Hsin-Yu Shih; Chih-Hung Huang; Li-Ting Li; Chia-Chun Chen; Hsu-Wei Fang
Journal:  Support Care Cancer       Date:  2014-02-06       Impact factor: 3.603

3.  16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation.

Authors:  Emmanuel Montassier; Eric Batard; Sébastien Massart; Thomas Gastinne; Thomas Carton; Jocelyne Caillon; Sophie Le Fresne; Nathalie Caroff; Jean Benoit Hardouin; Philippe Moreau; Gilles Potel; Françoise Le Vacon; Marie France de La Cochetière
Journal:  Microb Ecol       Date:  2014-01-09       Impact factor: 4.552

Review 4.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  Colonization by Enterobacteriaceae is crucial for acute inflammatory responses in murine small intestine via regulation of corticosterone production.

Authors:  Zélia Menezes-Garcia; Raquel Duque Do Nascimento Arifa; Leonardo Acúrcio; Camila Bernardo Brito; Júlia Oliveira Gouvea; Renata Lacerda Lima; Rafael Wesley Bastos; Ana Carolina Fialho Dias; Luana Pereira Antunes Dourado; Leandro F S Bastos; Celso Martins Queiroz-Júnior; Carlos Eduardo Dias Igídio; Rafael De Oliviera Bezerra; Leda Q Vieira; Jacques R Nicoli; Mauro Martins Teixeira; Caio T Fagundes; Daniele G Souza
Journal:  Gut Microbes       Date:  2020-06-23

6.  Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model.

Authors:  Margot Fijlstra; Mithila Ferdous; Anne M Koning; Edmond H H M Rings; Hermie J M Harmsen; Wim J E Tissing
Journal:  Support Care Cancer       Date:  2014-11-08       Impact factor: 3.603

7.  Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management.

Authors:  Alexander Stein; Wieland Voigt; Karin Jordan
Journal:  Ther Adv Med Oncol       Date:  2010-01       Impact factor: 8.168

Review 8.  Cancer and the gut microbiota: an unexpected link.

Authors:  Laurence Zitvogel; Lorenzo Galluzzi; Sophie Viaud; Marie Vétizou; Romain Daillère; Miriam Merad; Guido Kroemer
Journal:  Sci Transl Med       Date:  2015-01-21       Impact factor: 17.956

9.  Effects of granulocyte-colony stimulating factor on peritoneal defense mechanisms and bacterial translocation after administration of systemic chemotherapy in rats.

Authors:  Celal Cerci; Cagri Ergin; Erol Eroglu; Canan Agalar; Fatih Agalar; Sureyya Cerci; Mahmut Bulbul
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

10.  Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study.

Authors:  P Osterlund; T Ruotsalainen; R Korpela; M Saxelin; A Ollus; P Valta; M Kouri; I Elomaa; H Joensuu
Journal:  Br J Cancer       Date:  2007-09-25       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.